Dengue virus infection in Africa.

Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. · 2011

Read Dengue virus infection in Africa. by Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3381573.txt.

Introduction

Amarasinghe and co-authors reviewed dengue in Africa in 2011, where the disease's true scale was unknown. Reported cases had climbed worldwide, yet Africa reported few. The team gathered five decades of reports, from 1960 to 2010, plus antibody surveys and traveler cases.

Twenty-two African countries had reported local cases or outbreaks, and twelve more appeared only through infected travelers. Antibody findings suggested the virus circulates widely, so low case counts likely reflect missed diagnosis, weak testing, and other fevers crowding it out. Rival explanations include cross-protection from related viruses and less efficient local mosquitoes. Population studies of fever, they urge, are needed to size the problem.

Catalog record

CREATORAmarasinghe A, Kuritsk JN, Letson GW, Margolis HS.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3381573

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Dengue Virus Infection in Africa By Ananda Amarasinghe, Joel N. Kuritsky, G. William Letson, Harold S. Margolis Published in: Emerging Infectious Diseases DOI: 10.3201/eid1708.101515 ABSTRACT Reported incidence of dengue has increased worldwide in recent decades, but little is known about its incidence in Africa. During 1960–2010, a total of 22 countries in Africa reported sporadic cases or outbreaks of dengue; 12 other countries in Africa reported dengue only in travelers. The presence of disease and high prevalence of antibody to dengue virus in limited serologic surveys suggest endemic dengue virus infection in all or many parts of Africa. Dengue is likely underrecognized and underreported in Africa because of low awareness by health care providers, other prevalent febrile illnesses, and lack of diagnostic testing and systematic surveillance. Other hypotheses to explain low reported numbers of cases include cross-protection from other endemic flavivirus infections, genetic host factors protecting against infection or disease, and low vector competence and transmission efficiency. Population-based studies of febrile illness are needed to determine the epidemiology and true incidence of dengue in Africa. Dengue has emerged in recent decades as a worldwide public health problem, particularly in the Asia–Pacific and Americas–Caribbean regions (1–3). In Africa, the epidemiology and public health effect of dengue is not clear. Aedes spp. mosquitoes are widely distributed in Africa and can serve as vectors of dengue virus (DENV). When their distribution is combined with rapid population growth, unplanned urbanization, and increased international travel, extensive transmission of DENV is likely in Africa (Figure) (2,4). Over the past 5 decades, cases of epidemic or sporadic dengue have been reported in many countries in sub-Saharan Africa (5). Although sporadic cases of dengue hemorrhagic fever (DHF) have been reported in a few countries in Africa, no outbreaks have been reported (1). However, when compared with the Asia–Pacific and Americas–Caribbean regions, the epidemiology and effect of dengue in Africa has not been defined. A dengue outbreak in Cape Verde was recently reported (>3,000 cases), and the reappearance of dengue in Senegal after 20 years was also reported (6). To estimate the extent of DENV infection and dengue in Africa, we reviewed published literature and other sources for reports of this disease in persons 1iving in or traveling to this region. [Figure: Dengue and Aedes aegypti mosquitoes in Africa. Brown indicates 34 countries in which dengue has been reported, including dengue reported only in travelers, and Ae. aegypti mosquitoes. Light brown indicates 13 countries (Mauritania, The Gambia, Guinea-Bissau, Guinea, Sierra Leone, Liberia, Niger, Chad, Central African Republic, Republic of the Congo, Malawi, Zimbabwe, and Botswana) in which dengue has not been reported but that have Ae. aegypti mosquitoes. White indicates 5 countries (Western Sahara, Morocco, Algeria, Tunisia, and Libya) for which data for dengue and Ae. aegypti mosquitoes are not available.] SEARCH METHODS Published, peer-reviewed literature, published and unpublished country reports, and the World Health Organization (WHO) library database, including Dengue Net, were reviewed for 1960–2010 for the key terms “dengue” and “Africa.” In addition, we examined peer-reviewed published literature and other sources to determine the extent of disease among travelers returning from Africa. We searched for publications in English by using MEDLINE and EMBASE electronic databases, Euro Surveillance, and ProMED-mail posts. A review for dengue reports in languages other than English did not find any reports that would change the conclusions of this article. Additionally, references in each paper identified during searches were checked. Those references not already identified by the search were reviewed. Abstracts presented at international forums were included if they contained epidemiologic, entomologic, or virologic data pertaining to dengue in Africa. REPORTED DENGUE IN AFRICA Dengue was reported in Africa in the late 19th and early 20th centuries. Epidemics were reported in Zanzibar (1823, 1870), Burkina Faso (1925), Egypt (1887, 1927), South Africa (1926–1927), and Senegal (1927–1928) (1,5,7). The epidemic in South Africa was confirmed by retrospective neutralizing antibody testing in the mid-1950s, but the other reported epidemics were not laboratory confirmed and therefore may not have been dengue. During the 50 years from 1960 through 2010, twenty laboratory-confirmed dengue outbreaks were reported in 15 countries in Africa; most were from eastern Africa. Nearly 300,000 cases were reported in 5 large epidemics in the Seychelles (1977–1979), Réunion Island (1977–1978), Djibouti (1992–1993), Comoros (1992–1993), and Cape Verde (2009) (6–9). DENV was first isolated in Africa in Nigeria in the 1960s (10). Subsequently, all 4 DENV serotypes have been isolated in Africa (1). DENV-2 has been reported to cause most epidemics, followed by DENV-1 (8,9). Available data strongly suggest that DENV transmission is endemic to 34 countries in all regions of Africa (Figure, Table). Of these countries, 22 have reported local disease transmission, 20 have reported laboratory-confirmed cases, and 2 (Egypt and Zanzibar) have reported only clinical cases that were not laboratory confirmed. In the remaining 12 countries, dengue was diagnosed only for travelers returning to countries to which dengue was not endemic but never reported as occurring locally in these 12 countries (Table). [Table: Countries in Africa with evidence of dengue virus transmission*] DENGUE AMONG TRAVELERS/EXPATRIATES RETURNING FROM AFRICA The European Network on Imported Infectious Disease Surveillance and other published data have reported 27 countries in Africa as locations where travelers/expatriates from regions to which dengue was not endemic acquired dengue (Table) (11–15). Among travel-acquired dengue cases reported among persons from Europe, only 2%–8% had visited Africa (11–14). Although 54%–61% and 25%–31% of returning travelers with dengue returned from Asia and Latin America, respectively, Africa seems somewhat underrepresented with respect to dengue. However, this finding is not the result of a paucity of visits among travelers from countries to which dengue is not endemic. Wilson et al. reported for the GeoSentinel Surveillance Network of the International Society of Travel Medicine and the Centers for Disease Control and Prevention that travelers reporting illness have disproportionately visited Africa (15). Febrile illness was more frequently reported for travelers to sub-Saharan Africa (371 febrile illnesses/1,000 patients) than to any other region, followed by Southeast Asia (248/1,000) and South America (143/1,000) (11). Similar to reported global dengue endemicity patterns by region, travelers with dengue came more frequently from Southeast Asia and South America than Africa (11). PREVALENCE OF DENV INFECTION IN AFRICA Although outbreaks of dengue have been reported, data on incidence or prevalence are not available for Africa. A study in Nigeria determined the prevalence of flavivirus infections among 1,816 children and adults from urban and rural areas in samples obtained mainly during the early 1970s. Virus-specific hemagglutination inhibition testing showed that the prevalence of immunity was 38% for DENV-1 infection, 45% for DENV-2 infection, 43% for yellow fever virus infection, and 49% for West Nile virus infection (16). Serum specimens were also tested by suckling mouse neutralization of DENV-2. The authors concluded that because a high proportion of specimens with antibody to DENV-2 were confirmed by neutralization and because many had only monotypic antibody, the prevalence results were not likely confounded by cross-reactive antibody to other flaviviruses. In addition, this study showed an increase in prevalence of antibodies against DENV with age, which suggests endemic infection (16). Collenberg et al. reported that the prevalence of antibodies against DENV determined by immunoglobulin G indirect ELISA among a sample of pregnant

Read the complete text